NPPA ropes in patent office to decide on pleas for price cap exemptionIndia's drug pricing regulator, NPPA, is increasing scrutiny of pharmaceutical companies seeking price exemptions. The NPPA is collaboratin...
Indian drug firms recall products in US marketWhile Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in the US market.
Zydus gets USFDA nod for schizophrenia treatment drugThe company has got final approval from the USFDA to market the drug in the strengths of 25 mg, 50 mg, 100 mg and 200 mg, Zydus Cadila said...